I think it's a logical step. The same suitor may also be our partner for the rest of the platform. Just waiting to see how it plays out. Dr. B can make it happen. The wild card is prurisol and compassionate use for both brilacidin OM and prurisol if the data supports what we believe will be good enough to compete.